Bacterial Pneumonia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific... Research Beam Model: Research Beam Product ID: 153545 2500 USD New
Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
 
 

Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

  • Category : Pharmaceuticals
  • Published On : November   2014
  • Pages : 142
  • Publisher : GlobalData
 
 
 
Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bacterial Pneumonia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bacterial Pneumonia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Bacterial Pneumonia Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Bacterial Pneumonia 32
Sep 11, 2014: Genocea Commences Phase 2a Trial for GEN-004, Universal Pneumococcal Vaccine Candidate 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Actavis plc 37
Clinical Trial Overview of Actavis plc 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
Cempra, Inc. 39
Clinical Trial Overview of Cempra, Inc. 39
Jacobus Pharmaceutical Company 40
Clinical Trial Overview of Jacobus Pharmaceutical Company 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
U.S. Bioscience, Inc 42
Clinical Trial Overview of U.S. Bioscience, Inc 42
Cubist Pharmaceuticals, Inc. 43
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 43
Bayer AG 44
Clinical Trial Overview of Bayer AG 44
Clinical Trial Overview of Top Institutes / Government 45
The National Institute of Allergy and Infectious Diseases 45
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 45
Pharmaceutical Research Unit, Jordan 47
Clinical Trial Overview of Pharmaceutical Research Unit, Jordan 47
National Heart, Lung, and Blood Institute 48
Clinical Trial Overview of National Heart, Lung, and Blood Institute 48
University of Pittsburgh 49
Clinical Trial Overview of University of Pittsburgh 49
Hospital Universitario Virgen del Rocio 50
Clinical Trial Overview of Hospital Universitario Virgen del Rocio 50
National Taiwan University Hospital 51
Clinical Trial Overview of National Taiwan University Hospital 51
University of Milan 52
Clinical Trial Overview of University of Milan 52
National Institutes of Health Clinical Center 53
Clinical Trial Overview of National Institutes of Health Clinical Center 53
University of Oxford 54
Clinical Trial Overview of University of Oxford 54
National Center for Research Resources 55
Clinical Trial Overview of National Center for Research Resources 55
Five Key Clinical Profiles 56
Appendix 140
Abbreviations 140
Definitions 140
Research Methodology 141
Secondary Research 141
About GlobalData 142
Contact Us 142
Disclaimer 142
Source 142
List Of Tables
List of Tables
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Bacterial Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 37
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 38
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2014* 39
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014* 40
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 41
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Bioscience, Inc, 2014* 42
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014* 43
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 44
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 45
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaceutical Research Unit, Jordan, 2014* 47
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 48
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 49
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Virgen del Rocio, 2014* 50
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 51
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014* 52
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014* 53
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 54
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 55
List Of Figures
List of Figures
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 141
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT